Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 36.89 |
---|---|
High | 37.09 |
Low | 35.18 |
Bid | 34.99 |
Offer | 38.37 |
Previous close | 36.26 |
Average volume | 579.44k |
---|---|
Shares outstanding | 50.34m |
Free float | 48.90m |
P/E (TTM) | 613.96 |
Market cap | 1.87bn USD |
EPS (TTM) | -0.0141 USD |
Data delayed at least 15 minutes, as of Jul 18 2025 21:00 BST.
More ▼
- Vericel to Report Second-Quarter 2025 Financial Results on July 31, 2025
- Vericel to Present at the Truist Securities MedTech Conference on Tuesday, June 17, 2025
- Vericel Reports First Quarter 2025 Financial Results and Raises Full-Year Profitability Guidance
- Vericel to Present at the Bank of America Securities 2025 Healthcare Conference on Wednesday, May 14, 2025
- Vericel to Report First-Quarter 2025 Financial Results on May 8, 2025
- Vericel to Present at Multiple Upcoming Investor Conferences
- Vericel Reports Fourth Quarter and Full-Year 2024 Financial Results
- Vericel to Report Fourth-Quarter and Full-Year 2024 Financial Results on February 27, 2025
- Vericel Announces Preliminary 2024 Financial Results, 2025 Financial Guidance and Increased Mid-Term Profitability Targets
- Vericel to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2025
More ▼